Answers are grounded in this paper and cite their sources.
Bone development requires coordinated chondrocyte maturation and osteoblast differentiation, but the contribution of glycosylation to these lineage programs remains incompletely defined. We investigated the role of ST3GAL1 -associated α-2,3 sialylation in postnatal skeletal development using public transcriptomic analysis, histology, single-cell RNA sequencing, in vitro differentiation assays, neonatal desialylation, and Ocn -Cre; St3gal1 flox/flox conditional knockout mice. Sialyltransferase genes, including St3gal1 , increased during skeletal development, and α-2,3 sialylation was dynamically enriched in growth plate and trabecular regions. Single-cell analysis showed preferential ST3GAL1 expression in osteoblast- and chondrocyte-associated populations. Global sialidase treatment reduced growth plate α-2,3 sialylation and was associated with impaired longitudinal growth and delayed ossification, supporting a tissue-level requirement for sialylation. In MC3T3-E1 and ATDC5 cells, St3gal1 knockdown reduced α-2,3 sialylation and attenuated osteogenic and chondrogenic differentiation, with changes in proliferation and apoptosis during hypertrophic induction. Conditional St3gal1 deletion in osteoblast-lineage cells reduced bone mass, impaired osteogenic marker expression, and delayed growth plate maturation. These findings support ST3GAL1 -associated α-2,3 sialylation as a contributor to skeletal lineage differentiation and postnatal bone development, while the direct sialylated substrates and non-cell-autonomous mechanisms remain to be defined.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.